Xenetic Biosciences Financials
Based on the key indicators related to Xenetic Biosciences' liquidity, profitability, solvency, and operating efficiency, Xenetic Biosciences is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.
Xenetic |
Understanding current and past Xenetic Biosciences Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Xenetic Biosciences' financial statements are interrelated, with each one affecting the others. For example, an increase in Xenetic Biosciences' assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Xenetic Biosciences' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Xenetic Biosciences. Check Xenetic Biosciences' Beneish M Score to see the likelihood of Xenetic Biosciences' management manipulating its earnings.
Xenetic Biosciences Stock Summary
Xenetic Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, research, and development of next-generation biologic drugs and novel orphan oncology therapeutics. Xenetic Biosciences, Inc. is headquartered in Framingham, Massachusetts. Xenetic Biosciences is traded on BATS Exchange in USA.| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| Business Address | 945 Concord Street, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.xeneticbio.com |
| Phone | 781 778 7720 |
| Currency | USD - US Dollar |
Xenetic Biosciences Key Financial Ratios
| Return On Equity | -0.42 | |||
| Return On Asset | -0.26 | |||
| Beta | 2.3 |
Xenetic Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xenetic Biosciences's current stock value. Our valuation model uses many indicators to compare Xenetic Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xenetic Biosciences competition to find correlations between indicators driving Xenetic Biosciences's intrinsic value. More Info.Xenetic Biosciences is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Xenetic Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Xenetic Stock
If you are still planning to invest in Xenetic Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xenetic Biosciences' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |